ICMR impact scale may deter research in public interest

Context

  • The Indian Council of Medical Research (ICMR) has proposed the Impact of Research and Innovation Scale (IRIS).

  • Purpose: To quantify the impact of biomedical, public health, and allied research funded by ICMR.

  • IRIS will be used to evaluate, fund, and prioritise research projects based on their “impact”.


What is IRIS?

  • A metric-based system that assigns โ€œPublication Equivalentsโ€ (PEs) to various research outputs.

  • 1 PE = Primary research paper or meta-analysis in peer-reviewed journals.

  • 10 PEs = Paper cited in a public policy or guideline.

  • 5 PEs = Patent granted.

  • 20 PEs = Commercial product in use.


Key Objectives

  • Create a standardised evaluation framework across disciplines.

  • Recognise non-academic forms of research impact (e.g., policy impact, product development).

  • Tie research impact assessment to funding decisions.


Advantages / Pros

  1. Standardisation of Impact:

    • Uniform framework to evaluate research across diverse fields (biochemistry, public health, engineering).

  2. Beyond Citations:

    • Recognises real-world outcomes like policy influence, product deployment, and patents, not just academic publication count.

  3. Funding Transparency:

    • Links funding to measurable outcomes; helps prioritise impactful research.

  4. Portfolio Diversification:

    • May encourage researchers to work on non-traditional outputs like guidelines, devices, and community health innovations.


Concerns / Criticism

  1. Lack of Theoretical Rigor:

    • PE as a metric lacks robust theoretical justification.

    • Influential non-empirical works (e.g., commentaries, conceptual papers) are assigned 0 PE โ€” undervaluing foundational thinking.

  2. Commercial Bias:

    • Commercial devices (20 PEs) are rated higher than policy influence (10 PEs).

    • Risks undermining public health initiatives and community-based research.

  3. Ethical & Equity Risks:

    • May pressure researchers toward commercial outcomes, away from public good-oriented research.

    • Could worsen ethical practices, especially in Indiaโ€™s already fragile research ethics ecosystem.

  4. Transparency Issues:

    • No clear methodology or public data on how PEs were assigned.

    • Lack of external peer review or Delphi method to arrive at consensus-based scoring.


Way Forward

  • Conduct a national Delphi study with researchers to assign PE values based on consensus.

  • Ensure full transparency of methodology and external validation.

  • Incorporate diverse indicators of impact: conceptual, policy, societal, and ethical.

  • Maintain balance between scientific rigour and public relevance.

  • Develop independent oversight mechanisms to monitor implementation.

Leave a Reply

Your email address will not be published. Required fields are marked *